179 related articles for article (PubMed ID: 35024179)
1. A Tumor-Specific Ferric-Coordinated Epigallocatechin-3-gallate cascade nanoreactor for glioblastoma therapy.
Mu M; Chen H; Fan R; Wang Y; Tang X; Mei L; Zhao N; Zou B; Tong A; Xu J; Han B; Guo G
J Adv Res; 2021 Dec; 34():29-41. PubMed ID: 35024179
[TBL] [Abstract][Full Text] [Related]
2. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
[TBL] [Abstract][Full Text] [Related]
3. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
Yao YF; Liu X; Li WJ; Shi ZW; Yan YX; Wang LF; Chen M; Xie MY
Life Sci; 2017 Jul; 180():151-159. PubMed ID: 27956351
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study.
Saeed NM; El-Naga RN; El-Bakly WM; Abdel-Rahman HM; Salah ElDin RA; El-Demerdash E
Biochem Pharmacol; 2015 Jun; 95(3):145-55. PubMed ID: 25701654
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.
Stearns ME; Amatangelo MD; Varma D; Sell C; Goodyear SM
Am J Pathol; 2010 Dec; 177(6):3169-79. PubMed ID: 20971741
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable hollow mesoporous bimetallic nanoreactors to boost chemodynamic therapy.
Shi Y; Chang L; Pan C; Zhang H; Yang Y; Wu A; Zeng L
J Colloid Interface Sci; 2024 Feb; 656():93-103. PubMed ID: 37984174
[TBL] [Abstract][Full Text] [Related]
8. Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells.
Chen L; Ye HL; Zhang G; Yao WM; Chen XZ; Zhang FC; Liang G
PLoS One; 2014; 9(1):e85771. PubMed ID: 24465696
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment (TME)-modulating nanoreactor for multiply enhanced chemodynamic therapy synergized with chemotherapy, starvation, and photothermal therapy.
Hao S; Zuo J; Huang H; Li W; Guo H; Liu M; Zhu H; Sun H
J Mater Chem B; 2023 Feb; 11(8):1739-1748. PubMed ID: 36723374
[TBL] [Abstract][Full Text] [Related]
11. Design and construction of IR780- and EGCG-based and mitochondrial targeting nanoparticles and their application in tumor chemo-phototherapy.
Bao J; Zhao Y; Xu J; Guo Y
J Mater Chem B; 2021 Dec; 9(48):9932-9945. PubMed ID: 34842269
[TBL] [Abstract][Full Text] [Related]
12. Intelligent design of iron-doped LDH nanosheets for cooperative chemo-chemodynamic therapy of tumors.
Zhang L; Li G; Ouyang Z; Yang R; Gao Y; Cao X; Bányai I; Shi X; Guo R
Biomater Sci; 2022 Apr; 10(8):2029-2039. PubMed ID: 35302125
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate inhibits doxorubicin-induced inflammation on human ovarian tissue.
Fabbri R; Macciocca M; Vicenti R; Caprara G; Piccinni MP; Paradisi R; Terzano P; Papi A; Seracchioli R
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996116
[TBL] [Abstract][Full Text] [Related]
14. A major green tea component, (-)-epigallocatechin-3-gallate, ameliorates doxorubicin-mediated cardiotoxicity in cardiomyocytes of neonatal rats.
Li W; Nie S; Xie M; Chen Y; Li C; Zhang H
J Agric Food Chem; 2010 Aug; 58(16):8977-82. PubMed ID: 20666448
[TBL] [Abstract][Full Text] [Related]
15. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.
Liang G; Tang A; Lin X; Li L; Zhang S; Huang Z; Tang H; Li QQ
Int J Oncol; 2010 Jul; 37(1):111-23. PubMed ID: 20514403
[TBL] [Abstract][Full Text] [Related]
16. Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models.
Chen TC; Wang W; Golden EB; Thomas S; Sivakumar W; Hofman FM; Louie SG; Schönthal AH
Cancer Lett; 2011 Mar; 302(2):100-8. PubMed ID: 21257259
[TBL] [Abstract][Full Text] [Related]
17. EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment.
Tsai LC; Hsieh HY; Lu KY; Wang SY; Mi FL
Nanomedicine (Lond); 2016 Jan; 11(1):9-30. PubMed ID: 26654241
[TBL] [Abstract][Full Text] [Related]
18. Duo of (-)-epigallocatechin-3-gallate and doxorubicin loaded by polydopamine coating ZIF-8 in the regulation of autophagy for chemo-photothermal synergistic therapy.
Chen X; Tong R; Liu B; Liu H; Feng X; Ding S; Lei Q; Tang G; Wu J; Fang W
Biomater Sci; 2020 Mar; 8(5):1380-1393. PubMed ID: 31916560
[TBL] [Abstract][Full Text] [Related]
19. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
[TBL] [Abstract][Full Text] [Related]
20. Spectroscopic and cytotoxicity studies on the combined interaction of (-)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin.
Guo Q; Liu M; Zhao Y; Wu Y; Liu J; Cai C; Shi Y; Han J
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117213. PubMed ID: 31177010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
